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Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF) is a severe tick-borne disease well recognized through Europe and
Asia where diagnostic tests and medical surveillance are available. However, it is largely neglected in Africa, especially in the
tropical rainforest of Central Africa where only sporadic human cases have been reported and date back to more than 30
years. We describe here an isolated human case that occurred in the Democratic Republic of the Congo in 2008 and
performed phylogenetic analysis to investigate whether it resulted from a regional re-emergence or from the introduction
of a novel virus in the area.
Methods and Findings: Near complete segment S and partial segment M sequences were characterized. Bayesian
phylogenetic analysis and datation were performed to investigate the relationship between this new strain and viral strains
from Africa, Europe and Asia. The new strain is phylogenetically close to the previously described regional genotype (II) that
appears to be specific to Central Africa. Phylogenetic discrepancy between segment S and M suggested genetic exchange
among local sublineages, which was dated back to 130–590 years before present.
Conclusions: The phylogenetic analyses presented here suggest ongoing CCHF virus circulation in Central Africa for a long
time despite the absence of reported human cases. Many infections have most probably been overlooked, due to the
weakness of healthcare structures and the absence of available diagnostic procedure. However, despite the lack of accurate
ecological data, the sporadic reporting of human cases could also be partly associated with a specific sylvatic cycle in
Central Africa where deforestation may raise the risks of re-emergence. For these reasons, together with the high risk of
nosocomial transmission, public health authorities’ attention should be drawn to this etiological agent.
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Introduction
Crimean-Congo hemorrhagic fever virus (CCHFV, family
Bunyaviridae, genus Nairovirus) is a tick-borne virus. It causes severe
illness throughout Africa, Asia, Southeast Europe and the Middle
East, with case fatality rates ranging from 3% to 30%. Its
worldwide distribution closely matches that of its main arthropod
vector, ixodid ticks belonging to the genus Hyalomma. Human
infection occurs through tick bites, contact with infected livestock,
or nosocomial transmission. The CCHFV negative-stranded RNA
genome is divided into a small (S), medium (M) and large (L)
segment.
Previous phylogenetic analysis of the S segment clustered strains
into 6 to 7 distinct phylogeographic groups: West Africa in group
I, Central Africa (Uganda and Democratic Republic of Congo
(DRC)) in group II, South Africa and West Africa in group III,
Middle East and Asia (that may be split into 2 distinct groups Asia
1 and Asia 2 [4]) in group IV, Europe and Turkey in group V,
and finally Greece in group VI [1–5]. However, some of these
phylogenetic lineages include strains separated by large spatial
distances (such as South Africa and West Africa) suggesting viral
migration, most likely via migratory birds transporting infected
ticks, or secondary introductions following importation of com-
mercial livestock. Comparative phylogenetic analysis revealed,
with a few exceptions, parallel clustering of the S and L segments,
while M segment reassortment seems more frequent [1,4–6].
During the last 60 years, CCHFV outbreaks have been
described in Asia, the Middle East and the Balkans, where the
virus has become endemic and caused several thousand human
cases. During the last decade, CCHFV has caused human disease
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2008, Georgia 2009) and has re-emerged in countries located
southwest of the Russian Federation after an absence of nearly 30
years [7]. By contrast, fewer than 100 cases have been recorded in
Africa [8], most of them in South Africa [9,10]. In East and West
Africa, enzootic CCHFV circulation has been shown by serological
surveys of cattle and virus isolation from ticks since the 1970s
[11,12] but until the outbreaks in Mauritania in 2004 [13] and
Sudan in 2008 [14], only sporadic human cases had been reported.
In Central African Republic (CAR), limited serological evidences of
CCHFV circulation in Zebu cattle has been provided [15] and
three viral strains were isolated from ticks between 1973 and 1976,
one of which lead to accidental infection of a laboratory worker
[11]. Subsequent isolations from ticks were performed in the
80’s [16] but no human case was reported. Despite the early
identification of human CCHFV infection in DRC (Kisangani,
1956), CCHFV occurrence in Central Africa has not been much
described and only sporadic human cases have been reported. One
month after having isolated the first CCHFV strain (strain Congo
3011) in newborn mice, Dr. Courtois became infected and this was
the last notified case in DRC, from which the strain Congo3010
was isolated [17,18]. The virus was next identified in Uganda
between 1958 and 1978. FifteenCCHFV strainswere isolatedfrom
febrile patients, of which nearly half were laboratory workers
having handled infectioussamples [11,17,18].From the geographic
information associated with the other patients, it can be inferred
that CCHFV was present both in the Entebbe area and in the Arua
district (previous West Nile district) located 350 km North, near the
border of Sudan. Three CCHFV strains were also isolated from
ticks and an early serological survey suggested cattle infection [11].
No other epidemiological or ecological information is available on
CCHFV in Central Africa or its borders, and no further cases have
been recorded.
In 2008, CIRMF (Centre International de Recherches Me ´di-
cales de Franceville, Gabon) identified CCHFV in a serum sample
received for etiological diagnosis of a case of hemorrhagic fever in
DRC. This is the only identification of CCHV in DRC for more
than 50 years. To determine whether it was due to introduction of
a novel virus or to re-emergence of a local genotype, we
determined the phylogenetic relationships between this virus
(hereafter referred to as Beruwe-2008) and previously described
isolates. Phylogenetic analysis showed that the Beruwe-2008 strain
belonged to the genotype previously identified in this area and thus
suggested that it had re-emerged. Local CCHFV persistence may
have been supported by a sylvatic natural cycle specific to Central
Africa, indicating that countries subject to major deforestation
may note an increasing number of human infections.
Methods
Ethics statement
Laboratory investigations were performed subsequently to the
WHO request for surveillance and early alert of hemorrhagic fever
outbreak in Central Africa. Because of the emergency settings
associated with the suspicion of such acute illnesses, no ethics
committee approval or written consent was deemed necessary.
The blood sample was taken by national healthcare workers of the
Lubutu hospital where the patient came for medical care. He was
informed that his blood sample will be further used for diagnostic
investigation and gave his verbal consent. The patient described
here is anonymous. The blood sample was next sent to the Institut
National de Recherche Biome ´dicale (Kinshasa, DRC) and then to
CIRMF upon WHO authorities. The study was approved by the
scientific committee of CIRMF.
Case description
The patient was a 26-year-old man living in Beruwe (Nord Kivu
province) in DRC, 325 km from Kisangani (Figure 1). He became
ill in the mining area where he worked. He complained of fever
and headache on day 1 and developed moderate bloody diarrhea
on day 2. Epistaxis, oral bleeding and hematuria occurred on day
3. He treated himself with ibuprofen and paracetamol during the
first three days. On day 4 after onset he additionally took quinine
and finally presented with severe asthenia and persistent bleeding
to Lubutu hospital, where the serum sample was taken. At this
stage the patient was subicteric, with bleeding at the venipuncture
site, but had only low-grade fever (37.6uC). He declared no contact
with wild animals during the previous three weeks but he had slept
in the forest. No further information on his outcome was available.
Molecular diagnosis
The patient’s serum was manipulated in biosafety level 4 (BSL-
4) conditions. The serum was first tested for Ebola and Marburg
viruses. As results were negative, investigations were next
performed for CCHFV. RNA was extracted with the QIAamp
viral RNA mini kit (Qiagen, Courtaboeuf, France) according to
manufacturer’s instructions. Reverse transcription (RT) and real-
time PCR amplification were performed with the High Capacity
cDNA RT kit and Taqman universal PCR master mix (Applied
Biosystems - Life Technologies Corporation, Carlsbad, Califor-
nia), and previously reported primers and probes [19]. Conven-
tional one-step RT-PCR was performed with CCHFV primers as
previously reported [20] and with SuperScript III one-step RT-
PCR system and Platinum Taq DNA polymerase (Invitrogen -Life
Technologies Corporation, Carlsbad, California). This yielded a
536-nucleotide fragment in the S segment, sequencing of which
confirmed CCHFV identification.
Genetic characterization
As viral isolation on Vero cells was unsuccessful, viral RNA was
extracted from the patient’s serum as described above, and was
used for RT-PCR amplification with Platinum Taq DNA
Author Summary
Crimean-Congo hemorrhagic fever virus (CCHFV) is trans-
mitted to humans through tick-bite or contact with
infected blood or tissues from livestock, the main
vertebrate hosts in a peri-domestic natural cycle. With
numerous outbreaks, a high case fatality rate (3%–30%)
and a high risk for nosocomial transmission, CCHFV
became a public health concern in Europe and Asia.
However virus surveillance in Africa is difficult due to the
limited sanitary facilities. Especially, CCHFV occurrence in
Central Africa is very poorly described and seems highly in
contrast with the temperate to dry environments to which
the virus is usually associated with. We described a single
human infection that occurred in Democratic Republic
of the Congo after nearly 50 years of absence. The
phylogenetic analysis suggests that CCHFV enzootic
circulation in the area is still ongoing despite the absence
of notification, and thus reinforces the need for the
medical workers and authorities to be aware of the
outbreak risk. The source of infection seemed associated
with a forest environment while no link with the usual
agro-pastoral risk factors could be identified. More
accurate ecological data about CCHFV enzootic cycle are
required to assess the risk of emergence in developing
countries subjected to deforestation.
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alignments (Table 1). Three overlapping PCR products allowed
near-complete characterization of the S segment coding sequence
(GenBank accession number HQ849545) and partial character-
ization of the M segment (GenBank accession number
HQ849546). Amplification of the L segment was unsuccessful,
being limited by the sample quantity.
Phylogenetic analysis
A total of 44 complete sequences for segment S and 38 complete
sequences for segment M were retrieved from GenBank (Table S1
in online supporting information). Nucleotides were aligned
according to the amino-acid profile using the Translation Align
algorithm implemented in Geneious software [21]. Initial
phylogenetic analyses were performed with MrBayes V3.1
[22,23] using a GTR+gamma+invariant site substitution model
for 4 million MCMC chain iterations sampled every 100
generations, corresponding to 40 000 trees (data not shown).
Following confirmation of the tree topology from MrBayes, the
tip-dated coding alignments were submitted to Bayesian inference
of node ages by using BEAST V1.4.7 [24] under the assumption of
a codon-based substitution model (SRD06) and an uncorrelated
Figure 1. Geographic distribution of CCHFV in Africa. Genotypes I, II, III and IV are indicated in blue, green, orange and mauve, respectively.
Undetermined genotypes are in grey. Stars represent human infections diagnosed in Democratic Republic of the Congo (DRC). CAR: Central African
Republic.
doi:10.1371/journal.pntd.0001350.g001
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and constant population growth models. The Expansion model
yielded the best results, as indicated by ESS statistics and Bayes
factor analysis of the posterior probability trace in TRACER.
Sixty million generations were sampled every 1000 states,
corresponding to 60 000 trees, that were annotated with
TreeAnnotator and visualized with FigTree V1.3.1 from the
BEAST package.
Results and Discussion
In 2008 we received a serum sample for etiological diagnosis of
a case of hemorrhagic fever in DRC. The patient’ serum was
handled under BSL-4 facilities for RNA purification and tested
positive for CCHFV by real-time PCR and conventional
amplification with previously described detection systems
[19,20]. The patient became ill in Beruwe, approximately
325 km from Kisangani, where the only 2 previously reported
cases of CCHFV in DRC occurred in 1956 (Figure 1). The patient
worked in a mining area near a forest environment and didn’t
seem linked to agro pastoral activities. As this was the only
identified case of CCHV in DRC for more than 50 years, we
performed a phylogenetic analysis to determine whether it was due
to introduction of a novel virus or re-emergence of a local
genotype.
Virus isolation in Vero cells was unsuccessful, presumably owing
to virus degradation subsequently to difficulties and delays of
transportation. Genetic characterization was thus based on RT-
PCR of RNA extracted from the patient’s serum. As reassortment
usually affects the M segment, priority was given to sequencing
segments S and M, while segment L amplification was limited by
sample quantity and was unsuccessful. Near-complete character-
ization of the segment S coding sequence was achieved, yielding
1501 contiguous nucleotides; the 59 end was missing, presumably
owing to RNA degradation. A 1001-nucleotide fragment was
generated for segment M, corresponding to nucleotide positions
2382 to 3380 of the Congo3010-1956 glycoprotein coding
sequence (DRC strain).
Pairwise nucleotide comparison of the Beruwe-2008 segment S
sequence with those of the most closely related strains Congo3010-
1956 (DRC) and Semunya-1958 (Uganda) – showed 92.4% and
92.0% similarity, respectively. In segment M the pairwise identities
were 96.1% and 93.8% respectively. Identity between the Beruwe-
2008 strain and strains belonging to other genetic groups ranged
from 82.2% to 87.6% in segment S and from 72.5% to 81.3% in
segment M (Table 2).
Bayesian phylogenetic analysis with a molecular clock assump-
tion was applied to segment S (Figure 2A) and M (Figure 2B)
datasets. Both methods yielded tree topologies largely matching
the phylogeographic groups previously defined from complete
segments S and M [1–3]. In both segments, and with posterior
probabilities reaching 1, the Beruwe-2008 sequence grouped with
the aforementioned DRC and Uganda strains forming lineage II
Table 1. Primers used for CCHFV genetic characterization of the S and M segments.
Segment S
Fragment 1 (590 bp)
1
st round CCHF-MU: TCTCAAAGATATCGTTGCC CCHF-ER7: GAATTAGGGAAGCAACCAAG
Fragment 2 (550 bp)
1
st round CCHF-F2b: AAAGAGATGTTGTCAGACATGAT CCHF-R2b: GTTTCTTTCCCCACTTCATTGG
2
nd round CCHF-F3b: GAAGAAGGAACTTGATCCTCAA CCHF-R2b
Fragment 3 (536 bp) [19]
1
st round CCHF-F2: TGGACACCTTCACAAACTC CCHF-R3: GACAAATTCCCTGCACCA
Segment M
Fragment 1 (280 bp)
1
st round CCHF-M1F: AATGCAATAGATGCTGAAATGCA CCHF-M2R: TTGYTTGCYTC1AYRGTYGC
2
nd round CCHF-M1F CCHF-M1R: GAYTGRACTGG1GAYAWYGAAAC
Fragment 2 (420 bp)
1
st round CCHF-M2F: CAAGTRTCRGAGTCAACRGG CCHF-M2R: TTGYTTGCYTC1AYRGTYGC
2
nd round CCHF-M3F: TGGCTCTRAAGAGRAGYTGYTGGATRA CCHF-M3R: TTRCARACRGCYAGCATRACATT
Fragment 3 (510 bp)
1
st round CCHF-M4F: GAGTC1CAYAAATGCTAYTGYAGTCT CCHF-M4R: ACTGAACTCCAGCTAAGTGCTA
2
nd round CCHF-M4F CCHF-M5R: GTTGAYTGRACATTRATTGCYCCCCA
Sequences are reported in 59-39 orientation.
doi:10.1371/journal.pntd.0001350.t001
Table 2. P-distances between the Beruwe-2008 sequences
and other sequences included in the phylogenetic analysis.
P-distance range (%)
Segment S Segment M
Group 1: West Africa [16.1–16.4] [18.7–19.5]
Group 2: Central Africa [7.6–8] [3.9–6.2]
Group 3: South & West Africa [14.1–15] [24.6–27]*
Group 4: Asia-Middle East [12.4–14.8]
Group 5: Europe-Turkey [13.2–13.8] [24.4–25.1]
Group 6: Greece [17.8] [27.5]
*In segment M, phylogeographic groups III and IV are combined and the
reported p-distances include both groups.
doi:10.1371/journal.pntd.0001350.t002
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of segment L reassortment, the Beruwe-2008 strain most likely
belongs to the genotype previously identified in Central Africa,
thus representing viral re-emergence rather than introduction of
another genotype. In addition, the phylogenetic position of the
Beruwe-2008 strain inside this Central African clade differed
between the two segments, lying at the most ancestral branch in
segment S while sharing a more recent common ancestry with the
Congo3010-1956 strain from Kisangani in segment M. This is
highly suggestive of intra-genotypic reassortment, thus implying
co-circulation of these two DRC sub-lineages at this time.
However, though it may be less probable, we cannot exclude
definitively recombination between the two strains.
Our dating analysis of the S segment resulted in time
estimations slightly more recent than previously reported, but
nonetheless within the same range and in keeping with an ancient
origin of CCHF viruses [2]. The MRCA (most recent common
ancestor) for the whole CCHFV species was estimated to have
arisen 2518 years before present (BP) (95% High Posterior Density
(HPD): 820-5281), the lineage II split-off was dated to 1484 years
BP (95% HPD: 583-3389) and the MRCA of the three Central
African strains was estimated at 587 years BP (95% HPD: 200-
1327). In the M segment, the MRCA estimates were slightly more
recent, most probably owing to the use of partial rather than
complete coding sequences and to different evolution of the two
genes. This resulted in MRCA estimates of 1955 years BP for the
Figure 2. Phylogenetic analysis of CCHFV in segments S and M. Caption A: analysis performed on 1501 nucleotides of segment S (near
complete sequence). Caption B: analysis performed on partial segment M sequence, 1001 nucleotides long. Genotypes are indicated in roman
numerals, named according to Caroll et al. [2] with the equivalent group nomenclature according to Chamberlin et al. [4] indicated in brackets: I –
West Africa (Africa 1); II – Central Africa (Africa 2); III – South and West Africa (Africa 3); IV – Middle East/Asia, divided into groups IVa and IVb
respectively corresponding to groups Asia 1 and Asia 2 acoording to [4]; V – Europe/Turkey (Europe 1); VI- Greece (Europe 2). The sequence from this
study is highlighted in gold. Sequences are named as follows: country_strain_sampling year_host. Posterior probabilities are indicated above
branches, followed by node age estimations. For clarity, posterior probability values below 0.6 and date estimates for the terminal branches were
removed. The scale bar corresponds to evolutionary distance in years.
doi:10.1371/journal.pntd.0001350.g002
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Central African strains (95%HPD: 114-407) and 129 years BP
(95% HPD: 75-228) for the two DRC strains. The genotype II
split-off was estimated to have occurred 646 years BP, but the
differences in the tree topologies prevented a true node age
comparison with segment S.
CCHV genotype II has been identified only in DRC and
Uganda, while different CCHV lineages have been identified in
neighboring countries to the north. Multiple genotypes have been
identified in CAR, belonging to groups IV and III [2,20], the latter
also being encountered in Sudan [14]. By contrast no other
genotype has been identified in Central Africa, for which reports
on CCHFV are scarce and date back to 30 years. Hence, the data
currently available suggest that genotype II is specific to central
Africa. In DRC, CCHV has been reported only once, 50 years
ago, but our data strongly suggest that the same genotype is still
actively circulating.
Of note, the MRCA estimates presented here are in agreement
with ancient divergence of this lineage (around 1000 years ago),
but whether or not this split-off was linked to virus adaptation to
Central Africa cannot be assessed. However, as the MRCA of the
three strains was dated back to 683 to 243 years BP (Figure 2A and
B respectively), one might reasonably assume that the association
of genotype II with this area goes back to this time period and thus
did not result from very recent introduction. In addition, the co-
circulation of different sub-lineages supports the possibility that
ongoing CCHFV circulation occurred in the same area for some
time. However, as the reassortment event would have taken place
approximately 120 years BP, there is no evidence that CCHFV
has been permanently circulating inside the Beruwe microhabitat,
and we cannot exclude the possibility that this virus was very
recently (re)introduced.
In addition to the CCHFV genotypic specificity for Central
Africa, its occurrence in the tropical rainforest contrasts strongly
with the ecological characteristics of other areas in which CCHFV
has been isolated [11]. Indeed, the enzootic distribution of
CCHFV mostly coincides with temperate to dry or semi-dry
climates in the forests, steppes and savannahs of Eurasia and West,
East and South Africa. In these environments, domestic animals
and their associated ticks are major agents of rural enzootic cycles
affecting nearby human populations [11,25]. Despite the lack of
accurate ecological data, the occurrence of CCHFV in Central
Africa and its apparent genotypic specificity may suggest a
distinctive sylvatic natural cycle in the deep tropical forest
characterized by high rainfall, specific wildlife species, and a low
density of domestic animals. Interestingly, co-speciation or long-
term association with specific tick species has been previously
suggested to explain the geographical distribution of CCHV
genetic variants in Russia and Central Asia [26]. Such a sylvatic
cycle, involving specific vectors and hosts with few contacts with
human populations, could partly explain the lack of outbreaks and
the sporadic nature of recorded human cases. In addition, as
CCHFV is known to have been present in Central Africa for
decades, and as human populations often live in isolated villages,
many human infections may have been overlooked. However
increasing invasion and destruction of rainforest habitats may lead
to a higher risk of human CCHFV cases in future.
Hence, despite 30 years without a single reported case, the data
presented here suggest that CCHFV continues to circulate in
Central Africa. More information on the epidemiology and the
natural cycle of CCHFV in this ecosystem is required to assess its
potential for emergence, notably in Gabon and Republic of the
Congo. However health authorities and medical staff should be
aware of the possibility of viral (re)emergence and of the high risk
of nosocomial transmission.
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